Showing results (1751-1760 of 1,849) with videos related to

Sort By:
Pageof 185
Life Science Alliance|June 17, 2021
Dissection-independent production of Plasmodium sporozoites from whole mosquitoesJoshua Blight, Katarzyna A Sala, Erwan Atcheson, et al.
The Lancet. Oncology|June 24, 2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialCorinne Faivre-Finn, Michael Snee, Linda Ashcroft, et al.
The Journal of Investigative Dermatology|April 19, 2026
The role of biosimilars in enhancing global access to psoriasis treatmentYasmina Behlock, Sean P Gavan, Thomas Graier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2019
Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized TrialNeil Bayman, Wiebke Appel, Linda Ashcroft, et al.
Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.
The Lancet Regional Health. Europe|September 24, 2021
Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry studyEvangelos Kontopantelis, Mamas A Mamas, Roger T Webb, et al.
ACS Catalysis|July 4, 2020
Cu-Catalyzed Hydroboration of Benzylidenecyclopropanes: Reaction Optimization, (Hetero)Aryl Scope, and Origins of Pathway SelectivityJose M Medina, Taeho Kang, Tuğçe G Erbay, et al.
The Lancet. HIV|October 2, 2015
Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trialWerner Leber, Heather McMullen, Jane Anderson, et al.
The Lancet. Haematology|September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trialGordon Cook, A John Ashcroft, Ethan Senior, et al.
Pageof 185